Institution Directory

Clinical trials at Stanford Medicine

Sites in Stanford & Palo Alto, CA

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 6:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1370

Shown on this page

Current sort

Live official records

Conditions: Amblyopia
Interventions: Patching, Glasses; Other
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 3 Years to 13 Years
Enrollment: 544 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 68
States / cities: Birmingham, Alabama • Glendale, Arizona • Phoenix, Arizona + 57 more

Conditions: Major Depressive Disorder
Interventions: Active Single-Pulse TMS, Sham Single-Pulse TMS, TARGET-optimized TMS, Non-optimized (Open-Loop) TMS, EEG Recording, Intracranial EEG (iEEG) Recording; Device · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 145 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Iowa City, California • Stanford, California

Conditions: Cardiac Sarcoidosis
Interventions: Baricitinib (LY3009104) 4 mg; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes, Diabetes, Retinopathy, Neuropathy, Nephropathy, Blood Pressure, Cardiovascular Risk, Microvascular
Interventions: observational study; Other
Lead sponsor: Jaeb Center for Health Research; Other
Eligibility: 12 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 18
States / cities: Birmingham, Alabama • Los Angeles, California • Palo Alto, California + 15 more

Conditions: Carcinomas (Including Squamous Cell and Adenocarcinoma), Neoplasms
Interventions: blood draw; Procedure
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2032
U.S. locations: 1
States / cities: Stanford, California

Conditions: Soft Tissue, Lymphoma, Osteosarcoma
Interventions: PET/MR imaging, MR imaging, PET/CT imaging; Diagnostic Test
Lead sponsor: Stanford University; Other
Eligibility: Up to 40 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Early Breast Cancer
Interventions: Endocrine therapy interruption; Other
Lead sponsor: ETOP IBCSG Partners Foundation; Network
Eligibility: 18 Years to 42 Years · Female only
Enrollment: 518 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2028
U.S. locations: 103
States / cities: Los Angeles, California • Palo Alto, California • San Diego, California + 77 more

Conditions: Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia (CMML), Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2, Refractory Chronic Myelomonocytic Leukemia, CMML, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia Post Cytotoxic Therapy, Acute Myeloid Leukemias, Refractory Acute Myeloid Leukemia (AML), Acute Monocytic Leukemia
Interventions: STX-0712; Biological
Lead sponsor: Solu Therapeutics, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 7
States / cities: Stanford, California • Tampa, Florida • Boston, Massachusetts + 4 more

Conditions: AAA - Abdominal Aortic Aneurysm
Interventions: Not listed
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2042
U.S. locations: 45
States / cities: Little Rock, Arkansas • Irvine, California • Los Angeles, California + 38 more

Conditions: Propionic Acidemia
Interventions: Not listed
Lead sponsor: ModernaTX, Inc.; Industry
Eligibility: 2 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 6
States / cities: Stanford, California • Baltimore, Maryland • Ann Arbor, Michigan + 3 more

Conditions: Neutral Lipid Storage Disease
Interventions: Not listed
Lead sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan; Other
Eligibility: Not listed
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2028
U.S. locations: 2
States / cities: Stanford, California • New York, New York

Conditions: B-cell Acute Lymphoblastic Leukemia
Interventions: Tisagenlecleucel; Biological
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 1 Day to 25 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 6
States / cities: Los Angeles, California • Stanford, California • Aurora, Colorado + 3 more

About this Stanford Medicine institution page

What this page lists: ClinicalTrials.gov records that list Stanford Medicine in Stanford & Palo Alto, CA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Stanford Medicine

Filter and sort this campus

Live official records

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

Optimizing Brain Excitability in Depression

A Trial of Baricitinib in Patients With Cardiac Sarcoidosis

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

Pediatric PET/MR Image Registry

Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

A Retrospective Study to Characterize Participants With Propionic Acidemia

International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases

A Second Infusion (Early Reinfusion) of Tisagenlecleucel in Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia(B-ALL)

About this Stanford Medicine institution page